Cargando…
Safety and Efficacy of Treatment for Scolios Is Secondary to Spinal Muscular Atrophy Fused to Lumbar 5 Level
INTRODUCTION: Patients with spinal muscular atrophy (SMA) usually have progressive scoliosis. Although fusion of the sacrum or pelvis has been recommended for correcting pelvic obliquity (PO), the procedure is invasive. This study determined as to whether performing instrumentation to the fifth lumb...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society for Spine Surgery and Related Research
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690103/ https://www.ncbi.nlm.nih.gov/pubmed/31435537 http://dx.doi.org/10.22603/ssrr.2017-0093 |
_version_ | 1783443145084633088 |
---|---|
author | Takei, Shoichiro Miyagi, Masayuki Saito, Wataru Imura, Takayuki Inoue, Gen Nakazawa, Toshiyuki Shirasawa, Eiki Uchida, Kentaro Akazawa, Tsutomu Takahira, Naonobu Takaso, Masashi |
author_facet | Takei, Shoichiro Miyagi, Masayuki Saito, Wataru Imura, Takayuki Inoue, Gen Nakazawa, Toshiyuki Shirasawa, Eiki Uchida, Kentaro Akazawa, Tsutomu Takahira, Naonobu Takaso, Masashi |
author_sort | Takei, Shoichiro |
collection | PubMed |
description | INTRODUCTION: Patients with spinal muscular atrophy (SMA) usually have progressive scoliosis. Although fusion of the sacrum or pelvis has been recommended for correcting pelvic obliquity (PO), the procedure is invasive. This study determined as to whether performing instrumentation to the fifth lumbar vertebra (L5) is safe and effective for scoliosis in patients with SMA. METHODS: Twelve patients with SMA underwent posterior spinal fusion and stopping instrumentation at the L5 level. We evaluated age at surgery, the duration of surgery, blood loss, complications, preoperative and postoperative Cobb angles, and PO. RESULTS: The mean age at surgery was 11.4 years; the mean duration of surgery was 319 minutes, and the mean blood loss was 1170 mL. The Cobb angle improved from 97.3° to 39.1° at 1 month postoperatively (correction rate, 60.9%) and to 42.3° at the final follow-up. PO was corrected from 27.8° to 13.1° at 1 month postoperatively (correction rate, 51.7%) and to 19.8° at the final follow-up. No complications were reported. All patients showed improvement in low back pain, with reduced difficulty while sitting. However, >10% correction loss of PO was observed in 6 patients with high preoperative PO. CONCLUSIONS: The correction rate of scoliosis in SMA patients with posterior spinal fusion and instrumentation to the L5 level was acceptable, and no complications occurred. Scoliosis associated with SMA was more rigid and severer than scoliosis associated with Duchenne muscular dystrophy. Correction rates of the Cobb angle and PO in SMA patients with instrumentation to L5 were similar to those in SMA patients with instrumentation to the sacrum or pelvis. Correction loss of PO was greater in patients with high preoperative PO than in those with low preoperative PO. Instrumentation and fusion to L5 for scoliosis in patients with SMA seems safe and effective, except in cases of high preoperative PO. |
format | Online Article Text |
id | pubmed-6690103 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Japanese Society for Spine Surgery and Related Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-66901032019-08-21 Safety and Efficacy of Treatment for Scolios Is Secondary to Spinal Muscular Atrophy Fused to Lumbar 5 Level Takei, Shoichiro Miyagi, Masayuki Saito, Wataru Imura, Takayuki Inoue, Gen Nakazawa, Toshiyuki Shirasawa, Eiki Uchida, Kentaro Akazawa, Tsutomu Takahira, Naonobu Takaso, Masashi Spine Surg Relat Res Original Article INTRODUCTION: Patients with spinal muscular atrophy (SMA) usually have progressive scoliosis. Although fusion of the sacrum or pelvis has been recommended for correcting pelvic obliquity (PO), the procedure is invasive. This study determined as to whether performing instrumentation to the fifth lumbar vertebra (L5) is safe and effective for scoliosis in patients with SMA. METHODS: Twelve patients with SMA underwent posterior spinal fusion and stopping instrumentation at the L5 level. We evaluated age at surgery, the duration of surgery, blood loss, complications, preoperative and postoperative Cobb angles, and PO. RESULTS: The mean age at surgery was 11.4 years; the mean duration of surgery was 319 minutes, and the mean blood loss was 1170 mL. The Cobb angle improved from 97.3° to 39.1° at 1 month postoperatively (correction rate, 60.9%) and to 42.3° at the final follow-up. PO was corrected from 27.8° to 13.1° at 1 month postoperatively (correction rate, 51.7%) and to 19.8° at the final follow-up. No complications were reported. All patients showed improvement in low back pain, with reduced difficulty while sitting. However, >10% correction loss of PO was observed in 6 patients with high preoperative PO. CONCLUSIONS: The correction rate of scoliosis in SMA patients with posterior spinal fusion and instrumentation to the L5 level was acceptable, and no complications occurred. Scoliosis associated with SMA was more rigid and severer than scoliosis associated with Duchenne muscular dystrophy. Correction rates of the Cobb angle and PO in SMA patients with instrumentation to L5 were similar to those in SMA patients with instrumentation to the sacrum or pelvis. Correction loss of PO was greater in patients with high preoperative PO than in those with low preoperative PO. Instrumentation and fusion to L5 for scoliosis in patients with SMA seems safe and effective, except in cases of high preoperative PO. The Japanese Society for Spine Surgery and Related Research 2018-04-27 /pmc/articles/PMC6690103/ /pubmed/31435537 http://dx.doi.org/10.22603/ssrr.2017-0093 Text en Copyright © 2018 by The Japanese Society for Spine Surgery and Related Research https://creativecommons.org/licenses/by-nc-nd/4.0/ Spine Surgery and Related Research is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Takei, Shoichiro Miyagi, Masayuki Saito, Wataru Imura, Takayuki Inoue, Gen Nakazawa, Toshiyuki Shirasawa, Eiki Uchida, Kentaro Akazawa, Tsutomu Takahira, Naonobu Takaso, Masashi Safety and Efficacy of Treatment for Scolios Is Secondary to Spinal Muscular Atrophy Fused to Lumbar 5 Level |
title | Safety and Efficacy of Treatment for Scolios Is Secondary to Spinal Muscular Atrophy Fused to Lumbar 5 Level |
title_full | Safety and Efficacy of Treatment for Scolios Is Secondary to Spinal Muscular Atrophy Fused to Lumbar 5 Level |
title_fullStr | Safety and Efficacy of Treatment for Scolios Is Secondary to Spinal Muscular Atrophy Fused to Lumbar 5 Level |
title_full_unstemmed | Safety and Efficacy of Treatment for Scolios Is Secondary to Spinal Muscular Atrophy Fused to Lumbar 5 Level |
title_short | Safety and Efficacy of Treatment for Scolios Is Secondary to Spinal Muscular Atrophy Fused to Lumbar 5 Level |
title_sort | safety and efficacy of treatment for scolios is secondary to spinal muscular atrophy fused to lumbar 5 level |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690103/ https://www.ncbi.nlm.nih.gov/pubmed/31435537 http://dx.doi.org/10.22603/ssrr.2017-0093 |
work_keys_str_mv | AT takeishoichiro safetyandefficacyoftreatmentforscoliosissecondarytospinalmuscularatrophyfusedtolumbar5level AT miyagimasayuki safetyandefficacyoftreatmentforscoliosissecondarytospinalmuscularatrophyfusedtolumbar5level AT saitowataru safetyandefficacyoftreatmentforscoliosissecondarytospinalmuscularatrophyfusedtolumbar5level AT imuratakayuki safetyandefficacyoftreatmentforscoliosissecondarytospinalmuscularatrophyfusedtolumbar5level AT inouegen safetyandefficacyoftreatmentforscoliosissecondarytospinalmuscularatrophyfusedtolumbar5level AT nakazawatoshiyuki safetyandefficacyoftreatmentforscoliosissecondarytospinalmuscularatrophyfusedtolumbar5level AT shirasawaeiki safetyandefficacyoftreatmentforscoliosissecondarytospinalmuscularatrophyfusedtolumbar5level AT uchidakentaro safetyandefficacyoftreatmentforscoliosissecondarytospinalmuscularatrophyfusedtolumbar5level AT akazawatsutomu safetyandefficacyoftreatmentforscoliosissecondarytospinalmuscularatrophyfusedtolumbar5level AT takahiranaonobu safetyandefficacyoftreatmentforscoliosissecondarytospinalmuscularatrophyfusedtolumbar5level AT takasomasashi safetyandefficacyoftreatmentforscoliosissecondarytospinalmuscularatrophyfusedtolumbar5level |